The following discussion contains forward-looking statements. Actual results
may differ significantly from those projected in the forward-looking statements.
See "Cautionary Note Concerning Forward-Looking Statements" on pages 3 and 4 of
this Transition Report. Factors that might cause future results to differ
materially from those projected in the forward-looking statements also include,
but are not limited to, those discussed in "Item 1A�Risk Factors" and elsewhere
in this Transition Report.
Alkermes plc is a fully integrated, global biopharmaceutical company that
applies its scientific expertise and proprietary technologies to research,
develop and commercialize, both with partners and on our own, pharmaceutical
products that are designed to address unmet medical needs of patients in major